Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug Applications

Journal Title: The AAPS Journal - Year 2008, Vol 10, Issue 1

Abstract

It is widely believed that acceptable bioequivalence studies of drugs with high within-subject pharmacokinetic variability must enroll higher numbers of subjects than studies of drugs with lower variability. We studied the scope of this issue within US generic drug regulatory submissions.

Authors and Affiliations

Barbara M. Davit, Dale P. Conner, Beth Fabian-Fritsch, Sam H. Haidar, Xiaojian Jiang, Devvrat T. Patel, Paul R. H. Seo, Keri Suh, Christina L. Thompson, Lawrence X. Yu

Keywords

Related Articles

Tissue Distribution Studies of Protein Therapeutics Using Molecular Probes: Molecular Imaging

Molecular imaging techniques for protein therapeutics rely on reporter labels, especially radionuclides or sometimes near-infrared fluorescent moieties, which must be introduced with minimal perturbation of the protein&#...

Pharmacodynamic Studies to Demonstrate Bioequivalence of Oral Inhalation Products

In the session on “Pharmacodynamic studies to demonstrate efficacy and safety”, presentations were made on methods of evaluating airway deposition of inhaled corticosteroids and bronchodilators, and syste...

Interspecies considerations in the evaluation of human food safety for veterinary drugs

Residues are composed of the parent drug and metabolites, and therefore interspecies comparisons must involve a consideration of comparative xenobiotic metabolism. The focus of this article will be the residue studies th...

Prediction of the Deposition of Dry Powder Aerosols

The trajectory, mass fluxes, and deposition of aerosolized particles in a complex tubular system have been predicted. A procedure based on Lagrangian stochastic modeling is proposed to enable the anticipation of such phe...

Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration

The online version of this article (doi:10.1208/s12248-015-9782-0) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP681531
  • DOI  10.1208/s12248-008-9015-x
  • Views 68
  • Downloads 0

How To Cite

Barbara M. Davit, Dale P. Conner, Beth Fabian-Fritsch, Sam H. Haidar, Xiaojian Jiang, Devvrat T. Patel, Paul R. H. Seo, Keri Suh, Christina L. Thompson, Lawrence X. Yu (2008). Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug Applications. The AAPS Journal, 10(1), -. https://europub.co.uk./articles/-A-681531